Nanovaccine Institute
The Nanovaccine Institute, established at Iowa State University in 2017, is a national transdisciplinary research consortium focused on advancing nano-based technologies to treat and prevent diseases. The institute aims to revolutionize public health outcomes through the design and promotion of nano-based vaccines and therapeutics.
Industries
N/A
Nr. of Employees
small (1-50)
Nanovaccine Institute
5001 ATRB, 2213 Pammel Drive, Ames, IA 50011-1101
Products
Universal influenza intranasal powder nanovaccine (preclinical)
A nanoparticle-based intranasal powder vaccine candidate intended to provide broad protection against influenza strains, designed for single-dose administration, ambient-temperature stability, and needle-free delivery.
Amphiphilic polyanhydride nanomedicines for antimicrobial-resistant pathogens (preclinical)
Nanoparticle formulations designed to deliver antimicrobials across protective barriers of parasites and resistant bacteria to improve efficacy and reduce systemic side effects.
Monoclonal antibody-based quantitative enzyme immunoassay for α-synuclein (research assay)
A quantitative enzyme immunoassay developed with specific monoclonal antibodies to detect pathological aggregates of α-synuclein for early diagnosis and research in neurodegenerative disease.
Universal influenza intranasal powder nanovaccine (preclinical)
A nanoparticle-based intranasal powder vaccine candidate intended to provide broad protection against influenza strains, designed for single-dose administration, ambient-temperature stability, and needle-free delivery.
Amphiphilic polyanhydride nanomedicines for antimicrobial-resistant pathogens (preclinical)
Nanoparticle formulations designed to deliver antimicrobials across protective barriers of parasites and resistant bacteria to improve efficacy and reduce systemic side effects.
Monoclonal antibody-based quantitative enzyme immunoassay for α-synuclein (research assay)
A quantitative enzyme immunoassay developed with specific monoclonal antibodies to detect pathological aggregates of α-synuclein for early diagnosis and research in neurodegenerative disease.
Expertise Areas
- Immunology
- Nanotechnology
- Materials science
- Microbiology
Key Technologies
- Polymeric nanoparticles
- Spray-drying nanoparticle manufacture
- Intranasal powder vaccine formulation
- Mucosal vaccine delivery